Thomas C Randall, MD

Gynecologic Oncology
Accepting New Patients
Virtual Visits/Telehealth

On the web

Profile Headshot

Profile Navigation

Overview

Thomas C Randall, MD is a gynecologic oncologist focused on meeting the individual needs and goals of women with gynecologic cancers. Dr. Randall provides care for all gynecologic cancers and for women at increased risk for gynecologic cancers. He has a particular focus on providing safe surgical care for women with gynecologic cancers, including advanced or recurrent ovarian cancer, uterine, cervical and vulvar cancer. Dr. Randall also performs surgery for complex gynecologic conditions. He has extensive experience and expertise in minimally invasive surgeries, and he has performed over 1000 surgeries with the DaVinci surgical robot. Additionally, Dr. Randall has expertise in radical cancer surgeries, including fertility sparing surgeries for gynecologic cancers.

Dr. Randall studied at Bowdoin College where he graduated Magna Cum Laude with Honors in English Literature and won the College Prize for Bowdoin from the Academy of American Poets. He then attended Johns Hopkins University School of Medicine and completed his residency in Obstetrics and Gynecology at Johns Hopkins Hospital. Next, he completed his fellowship in Gynecologic Oncology at the University of Pennsylvania in Philadelphia. Dr. Randall practiced gynecologic oncology and gynecologic surgery at the University of Pennsylvania and the Massachusetts General Hospital before coming to Columbia.

Dr. Randall is a leader in global health. He is the Chair of the Mentorship and Training Committee of the International Gynecologic Cancer Society, which supports 22 gynecologic oncology fellowships in low- and middle-income countries where gynecologic cancer surgery was not previously available. He also serves as an international mentor for gynecologic oncology fellowships in Haiti and Rwanda.

Areas of Expertise / Conditions Treated

  • Cervical Cancer
  • Cervical Dysplasia
  • Da Vinci Robotic Surgery
  • Endometrial Cancer
  • Gestational Trophoblastic Disease
  • Human Papillomavirus (HPV)
  • Laparoscopic Gynecologic Surgery
  • Placenta Accreta Spectrum (PAS)
  • Robotic Gynecologic Surgery
  • Uterine Cancer
  • Vaginal Cancer
  • Vulvar Cancer

Academic Appointments

  • Professor of Obstetrics and Gynecology at CUMC

Gender

  • Male

Schedule an Appointment

Virtual Visits/Telehealth

Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.

Schedule Virtual Visit

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

CUIMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
Primary
Phone:
212-305-3410
Open location in Google Maps

Insurance Accepted

Aetna

  • Aetna Signature Administrators
  • NYP Employee Plan
  • NY Signature
  • Student Health

Cigna

  • EPO
  • Great West (National)
  • PPO

Emblem/HIP

  • HMO
  • POS
  • Select Care (Exchange)
  • Vytra

Local 1199

  • Local 1199

Medicare

  • Traditional Medicare

Multiplan

  • Multiplan

MVP Health Care

  • Essential Plan

UnitedHealthcare

  • Compass (Exchange)
  • Empire Plan
  • Oxford Freedom
  • Oxford HMO
  • Oxford Liberty

WellCare

  • Medicare Managed Care

World Trade Center Health Plan

  • World Trade Center Health Plan

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • AB, 1985 English Literature, Magna Cum Laude, Bowdoin College
  • MD, 1991 The Johns Hopkins University School of Medicine
  • Residency: 1995 The Johns Hopkins Hospital
  • Fellowship: 1999 Hospital of the University of Pennsylvania

Committees, Societies, Councils

  • 2023 - Present: Work Options Committee, Massachusetts General Hospital, OBGYN
  • 2022 - Present: Mentorship Committee, Massachusetts General Hospital, OBGYN
  • 2023 - Present: Robotics Committee, Massachusetts General Hospital
  • 2014 - 2018: Executive Committee, Dana Farber/Harvard Cancer Center
  • 2016 - Present: Global Education Committee, International Gynecologic Cancer Society
  • 2014 - 2017: International Committee, American College of Surgeons
  • 2014 - 2017: International Committee, Society of Gynecologic Oncology
  • 2011 - 2014: Quality and Outcomes Committee, American College of Surgeons
  • 2007 - 2009: Executive Committee, Pennsylvania Hospital
  • 2006: Surgery Chair Search Committee, Pennsylvania Hospital
  • 2004: Radiology Chair Search Committee, Pennsylvania Hospital
  • 2002 - 2003: Clinical Practice Committee, American College of Surgeons
  • 2000 - Present: Fellow, American College of Surgeons
  • 1996 - Present: Member, American College of Surgeons
  • 1991 - Present: Fellow, American Congress of Obstetricians and Gynecologists

Editorial Boards

Ad Hoc Reviewer

  • Gynecologic Oncology
  • Obstetrics and Gynecology
  • American Journal of Obstetrics and Gynecology
  • The Annals of Surgery
  • The British Journal of Obstetrics and Gynecology
  • The Oncologist
  • Cancer Medicine

Other Editorial Roles

  • Co-editor, Global Oncology, The Oncologist
  • 2015-2022: Co-Editor, Global Oncology, Gynecologic Oncology Reports

Board Certifications

  • Gynecologic Oncology

Honors & Awards

  • 20103: Outstanding Ovarian Cancer Physician and Researcher, Sandy Rollman Foundation
  • 2006 - 2010, 2013: Top Doctor, Gynecologic Oncology, Philadelphia Magazine
  • 2006, 2013: Clarence C. Briscoe Award, Pennsylvania Hospital
  • 2005, 2012: Medical Student Teaching Award, Association of Professors in Obstetrics and Gynecology
  • 2000, 2003, 2007: National Faculty Award for Excellence in Resident Education, Council on Resident Education in Obstetrics and Gynecology (CREOG)
  • 2002: Teaching Recognition Award, MCP Hahnemann University, Department of Ob/Gyn

Research

Dr. Randall's research is focused on capacity building and quality improvement in gynecologic cancer care in low resource settings, as well as in cervical cancer prevention.

Grants

  • Composing CODAs to cervical cancer screening through an integrated
    CRISPR and fluorescent nucleic acid approach, 1U01CA279858-01
    Co-Investigator
    2023-2028
  • Co-I, U54 Automated Visual Examination and Geospatial Mapping for Cervical Cancer
    Screening Optimization in sub-Saharan Africa
    Principle Investigator
    Haberer, Celi, Obua
    2021-2026
  • A Pilot Study of Using Real World Data to Study Usage Patterns and
    Outcomes of HPV RNA Testing Using the Panther System, OM1 Industry Supported Trial
    Institution PI
    2020 - Present
  • Cervical cancer screening in southwest Uganda
    Pilot Funding PI
    First Mile Project, Wyss Foundation
    2019 - Present

Past Support

  • P20 Planning grant for research infrastructure and pilot studies in cancer and trauma in Rwanda
    Co-PI
    2017-2020
  • Cervical Cancer and HPV Diseases in Low and Middle Income Countries
    Unrestricted Educational Grant
    Principle Investigator
    Educational grant from the NCI Center for Global Health to Massachusetts General
    Hospital to support activities
    2014-2017
  • Race, Treatment and Endometrial Cancer Survival
    NIH (National Cancer Institute) CA98
    Co-Investigator (Katrina Armstrong, MD, PI)
    This study evaluated the SEER-Medicare database to better understand racial disparities in endometrial cancer survival
    2003-2007
  • Provider Specialty and Outcomes in Ovarian Cancer
    NIH (National Cancer Institute)
    Co-Investigator (Jeffrey Silber, MD, PhD, PI)
    This study used the SEER-Medicare database to evaluate survival from ovarian cancer based on the specialties of the providers performing surgery and chemotherapy
    2003-2007

Selected Publications

  1. Hill SK, Bempong-Ahun N, Okolo ID, Lalla AT, Worku D, Asres T, Philpotts L, Fallah PN, Varallo J, Corlew S, Kamfwa P, Parham GP, Hicks ML, Ibbotson G, Randall T. Improving access to safe, quality surgical care for gynecologic cancers through capacitybuilding interventions in low- and middle-income countries: A scoping review. Int J Randall 12 Gynaecol Obstet. 2024 May;165(2):552-561. doi: 10.1002/ijgo.15156. Epub 2023 Nov 5. PMID: 37927080..
  2. Ssedyabane F, Obuku EA, Namisango E, Ngonzi J, Castro CM, Lee H, Randall TC, Ocan M, Apunyo R, Annet Kinengyere A, Kajabwangu R, Tahirah Kisawe A, Nambi Najjuma J, Tusubira D, Niyonzima N. The diagnostic accuracy of serum and plasma microRNAs in detection of cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis. Gynecol Oncol Rep. 2024 Jun 4;54:101424. doi: 10.1016/j.gore.2024.101424. PMID: 38939506; PMCID: PMC11208915.
  3. Kajabwangu R, Izudi J, Bazira J, Ssedyabane F, Turanzomwe S, Birungi A, Ngonzi J, Bajunirwe F, Randall TC. Effect of metabolic syndrome and its components on the risk and prognosis of cervical cancer: A literature review. Gynecol Oncol Rep. 2024 Jun 22;54:101438. doi: 10.1016/j.gore.2024.101438. PMID: 39035032; PMCID: PMC11260376.
  4. Kajabwangu R, Bajunirwe F, Izudi J, Bazira J, Ssedyabane F, Kayondo M, Lugobe HM, Turanzomwe S, Randall TC, Ngonzi J. Late Stage at Diagnosis of Cervical Cancer and Its Correlates at a Large Regional Referral Hospital in Uganda: A Cross-Sectional Study. Cureus. 2024 Jun 19;16(6):e62702. doi: 10.7759/cureus.62702. PMID: 39036129; PMCID: PMC11259160.
  5. Kajabwangu R, Ssedyabane F, Tusubira D, Maling S, Kakongi N, Turyakira E, Namuli A, Galiwango M, Randall TC. High Rate of Loss to Follow-Up Among Patients Undergoing Treatment for Premalignant Cervical Lesions at Mbarara Regional Referral Hospital, Southwestern Uganda: A Retrospective Cohort Study. Cureus. 2023 Oct 5;15(10):e46542. doi: 10.7759/cureus.46542. PMID: 37927695; PMCID: PMC10625478.
  6. Kajabwangu R, Bajunirwe F, Izudi J, Bazira J, Farjardo Y, Ssedyabane F, Lugobe HM, Muhumuza J, Kayondo M, Turanzomwe S, Randall TC, Ngonzi J. Magnitude and trends in cervical cancer at Mbarara Regional Referral Hospital in South Western Uganda: Retrospective analysis of data from 2017-2022. PLOS Glob Public Health. 2024 Jan 19;4(1):e0002848. doi: 10.1371/journal.pgph.0002848. PMID: 38241290; PMCID: PMC10798516.
  7. Ssedyabane F, Randall TC, Kajabwangu R, Namuli A, Tusubira D, Kakongi N, Galiwango M, Maling S, Turyakira E, Atukunda EC. Development of a customized mHealth-based intervention to reduce loss to follow-up among patients undergoing treatment for cervical lesions at a rural referral Hospital, South Western Uganda. Gynecol Oncol Rep. 2024 Feb 24;52:101338. doi: 10.1016/j.gore.2024.101338. PMID: 38435345; PMCID: PMC10907155.
  8. Ssedyabane F, Niyonzima N, Nambi Najjuma J, Birungi A, Atwine R, Tusubira D, Randall TC, Castro CM, Lee H, Ngonzi J. Prevalence of cervical intraepithelial lesions and associated factors among women attending a cervical cancer clinic in Western Uganda; results based on Pap smear cytology. SAGE Open Med. 2024 May Randall 13 16;12:20503121241252265. doi: 10.1177/20503121241252265. PMID: 38764539; PMCID: PMC11100407.
  9. Fokom Domgue J, Pande M, Yu R, Manjuh F, Welty E, Welty T, Elit L, Lopez-Varon M, Rodriguez J, Baker E, Dangou JM, Basu P, Plante M, Lecuru F, Randall T, Starr E, Kamgno J, Foxhall L, Waxman A, Hawk E, Schmeler K, Shete S. Development, Implementation, and Evaluation of a Distance Learning and Telementoring Program for Cervical Cancer Prevention in Cameroon. JAMA Netw Open. 2022 Nov 1;5(11):e2240801. doi: 10.1001/jamanetworkopen.2022.40801. PMID: 36346631; PMCID: PMC9644259.
  10. Bercow AS, Rauh-Hain JA, Melamed A, Mazina V, Growdon WB, Del Carmen MG, Goodman A, Bouberhan S, Randall T, Sisodia R, Bregar A, Eisenhauer EL, Minami C, Molina G. Association of hospital-level factors with utilization of sentinel lymph node biopsy in patients with early-stage vulvar cancer. Gynecol Oncol. 2023 Feb;169:47-54. doi: 10.1016/j.ygyno.2022.11.026. Epub 2022 Dec 9. PMID: 36508758.

Reviews, Chapters, Monographs, and Editorials

  1. Randall TC, Rubin SC: Second-look laparotomy. Ovarian Cancer. Lippincott, Williams, and Wilkins, New York, NY, Page: 273-287, 2001.
  2. Randall TC, Mason BA: Hereditary breast and ovarian cancer. Postgrad Obstet Gynecol 21: 9, 2001.
  3. Randall TC, Rubin SC: Evaluation and management of hereditary ovarian cancer. Treatment of the Postmenopausal Woman. Lobo R (eds.). Lippincott-Raven, Philadelphia, PA, Page: 541-546, 1999.
  4. Randall TC, Rubin SC: Surgical management of ovarian cancer. Semin. Surg. Oncol 17: 173-180, 1999.
  5. Cohen J, Randall TC: Management of cystitis, urethritis, vaginitis and vulvitis in the patient with cancer. Cancer Obstetrics and Gynecology. Trimble EL, Trimble CL (eds.). Lippincott-Raven, Philadelphia, PA, Page: 99-132, 1999.
  6. Chu C, Randall TC, Mikuta JJ: Low malignant potential tumors of the ovary. Postgrad Obstet Gynecol 18: 1-6, 1998. 7.
  7. Randall TC, Rubin SC: Assessing a patient's risk for hereditary ovarian cancer: counseling patients at risk. OBG Mgmt Page: 37-46, October 1998.
  8. Randall TC, Kurman RJ: Progestins are the treatment of choice for most patients with endometrial hyperplasia: a management scheme for endometrial hyper-plasia based on age and desire for fertility. J Gynecol Techniques 3: 173-176, 1997. Randall 17
  9. Randall TC, Boyd J: Molecular genetics of gynecologic sarcomas. CME Gynecol Oncol 2: 182-189, 1997.
  10. Randall TC, Wallach EE: Tamoxifen: actions, benefits ad risks. Postgrad Obstet Gynecol 15: 1-12, 1995

Abstracts, Poster Presentations, and Exhibits

  1. Evans TB, Wilkinson-Ryan I, Randall TC: Robotic surgery for radical ovarian cancer debulking procedures. Gynecologic Oncology, March 2013.

For a complete list of publications, please visit PubMed.gov